ID   LK26
AC   CVCL_LH62
DR   Wikidata; Q54902672
RX   Patent=US4851332;
RX   PubMed=2580800;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8764.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized MORAb-003 (Farletuzumab) therapeutic antibody.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15328; Human FOLR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
RX   Patent=US4851332;
RA   Rettig W.J., Cordon-Cardo C., Koulos J.P., Lewis J.L. Jr.,
RA   Oettgen H.F., Old L.J.;
RT   "Choriocarcinoma monoclonal antibodies and antibody panels.";
RL   Patent number US4851332, 25-Jul-1989.
//
RX   PubMed=2580800; DOI=10.1002/ijc.2910350409;
RA   Rettig W.J., Cordon-Cardo C., Koulos J.P., Lewis J.L. Jr.,
RA   Oettgen H.F., Old L.J.;
RT   "Cell surface antigens of human trophoblast and choriocarcinoma
RT   defined by monoclonal antibodies.";
RL   Int. J. Cancer 35:469-475(1985).
//